Financials in USD. Standardized financial statements.
A compact view of how IDEX Biometrics ASA turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.15M | $4.09M | $2.84M | $1.09M | $3.72M | $250,332 | $1.95M | $4.46M | $39,702 | $191,396 |
| Revenue Growth? | +1.5% | +44.1% | +159.4% | -70.6% | +1386.9% | -87.2% | -56.2% | +11134.1% | -79.3% | 0.0% |
| Cost of Revenue? | $3.92M | $3.24M | $1.25M | $275,000 | $62,021 | $172,397 | $1.67M | $3.78M | -$46,641 | $55,414 |
| Gross Profit? | $231,730 | $848,000 | $1.59M | $820,000 | $96,264 | $77,935 | $285,574 | $679,736 | $86,343 | $135,982 |
| Gross Margin? | +5.6% | +20.7% | +55.8% | +74.9% | +2.6% | +31.1% | +14.6% | +15.2% | +217.5% | +71.0% |
| Operating Expenses? | $27.16M | $32.22M | $32.94M | $27.22M | $32.07M | $28.03M | $30.61M | $24.21M | $25.84M | $17.40M |
| Operating Income? | -$26.93M | -$31.37M | -$31.35M | -$26.40M | -$281.33M | -$258.62M | -$30.33M | -$23.53M | -$25.75M | -$17.27M |
| EBITDA? | -$273.86M | -$29.92M | -$29.54M | -$24.66M | -$273.12M | -$251.34M | -$242.56M | -$196.67M | -$25.19M | -$16.19M |
| Income Before Tax | -$270.55M | -$32.70M | -$32.46M | -$26.85M | -$283.22M | -$261.01M | -$30.61M | -$23.42M | -$25.97M | -$16.48M |
| Income Tax Expense | -$15,655 | -$36,000 | $90,000 | -$99,000 | $1.40M | $41,000 | $505,386 | $91,387 | $61,544 | $75,724 |
| Net Income? | -$26.71M | -$32.66M | -$32.55M | -$26.75M | -$32.42M | -$30.23M | -$31.11M | -$23.51M | -$26.03M | -$16.56M |
| EPS? | $-1.07 | $-0.16 | $-0.18 | $-0.17 | $-0.27 | $-0.05 | $-0.06 | $-0.04 | $-0.06 | $-0.04 |
| Diluted EPS? | $-1.07 | $-0.16 | $-0.18 | $-0.17 | $-0.27 | $-0.05 | $-0.06 | $-0.04 | $-0.06 | $-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality